What do people make of the move from the PER.C6 cell line to the CHO method?
Does this throw negative light back on Patrys ability to produce at scale using their own methods or does it show that large pharma is serious about the drug and wants to know if it can produce it with their preferred method?
I think this is a major announcement and fundamental change to the company.
- Forums
- ASX - By Stock
- PAB
- Ann: Patrys Reports Progress on Preclinical Programmes
Ann: Patrys Reports Progress on Preclinical Programmes, page-37
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $303 | 105K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 31260978 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 8671441 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 31260978 | 0.002 |
16 | 47951998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 8671441 | 9 |
0.004 | 9846005 | 10 |
0.005 | 5295522 | 9 |
0.006 | 3280952 | 6 |
0.007 | 4040000 | 2 |
Last trade - 16.10pm 31/01/2025 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |